Sign in
8-K

Current Report

CRISPR Therapeutics AG Filed Acc 0001193125-16-762737

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading d244547d8k.htm…